Skip to main content

Disease and Therapeutic Response Modeling Program

Fueled by foundational teaching and innovative research, the Disease and Therapeutic Response Modeling Program equips young scientists with diverse experiences in the design, application and interpretation of quantitative approaches that drive the evolution of medical therapies. 

13th Annual Indiana CTSI Disease and Therapeutic Response Modeling Symposium

The 13th Annual Indiana CTSI Disease and Therapeutic Response Modeling Symposium, will take place Tuesday, February 27 to Thursday, February 29, 2024, at Hine Hall in Indianapolis, IN on the vibrant IUPUI campus. This will be a collaboration between the Maternal and Pediatric Precision in Therapeutics (MPRINT) Hub and the Indiana CTSI Disease and Therapeutic Modeling & Simulation Program.

2024 Symposium Speakers

With the growth of model-informed drug discovery, the roles of quantitative pharmacologists and pharmacometricians are rapidly growing in the pharmaceutical industry. Since 2009, the Disease and Therapeutic Response Modeling Program (DTRMP) at Indiana University School of Medicine has trained over 30 postdoctoral fellows and graduate students, the majority of whom continue to play important research and leadership roles within the pharmaceutical industry. 

The DTRMP also plays a critical role in the Division of Clinical Pharmacology’s T32 Training Program, with most fellows attending didactic sessions offered on population pharmacokinetic/pharmacodynamic or physiologically based pharmacokinetic modeling, and many participating in pharmacometric-oriented research projects. Additionally, graduate students from Purdue University’s Department of Pharmacy Practice participate in the didactic sessions and are often actively mentored by DTRMP faculty.

Sara Quinney, PhDis the current Director of the Disease and Therapeutic Response Modeling Program.

Dr. Quinney serves as a standing member of the IU Simon Comprehensive Cancer Center Cancer Drug Development Working Group, is PI for the MPRINT DMKRCC (supporting pharmacometric modeling in maternal and pediatric therapeutics) and provides support to Drug Think Tank investigators. Additionally, the DTRMP supports PK/PD study design and analyses for multiple clinical studies.

For additional information on the DTRMP program, please contact Dr. Quinney.

In addition to the introductory Pharmacokinetics and Pharmacodynamics course that is part of the Clinical Pharmacology T32 didactics training program, the DTRMP has developed two advanced pharmacometrics courses: Physiologically-Based Pharmacokinetics and Population Pharmacokinetics. These courses are offered every-other year. Purdue University Department of Pharmacy Practice offers credit for these courses to their graduate students. Additionally, we offer a short-course in biostatistics for clinical pharmacologists. These courses utilize experts from the pharmaceutical industry to provide fundamental knowledge of pharmacometrics as well as cutting-edge applications. 

Course Name Director(s)
Clinical Pharmacokinetics and Pharmacodynamics Richard Bergstrom
Sara Quinney
Brian Overholser
Kevin Sowinski
Physiologically Based Pharmacokenetic Modeling Sara Quinney
Population Pharmacokinetics Michael Heathman
Biostatistics for Clinical Pharmacologists Richard Bergstrom

The DTRMP hosts an annual symposium, featuring international experts in pharmacometrics and quantitative sciences from academia, industry, and regulatory agencies.

In 2021, the symposium was held virtually over three days and included a number of interactive breakout sessions to provide networking and mentorship opportunities for trainees.

The 2022 symposium was held February 16-18, 2022.  Speakers included Sander Vinks (University of Cincinnati), Christina Frederich (Rosa), Craig Goergen (Purdue University), Sebastian Wicha (University of Hamburg), Rada Savic (UCSF), Allison Hill (John Hopkins), lan Pearlson (Los Alamos Laboratories), Denise Kirschner (University of Michigan), and speakers from Eli Lilly, Abbvie, Metrum Research Group, and the FDA.

The 2023 symposium was held February 22-24, 2023. We welcomed more than 260 guests at our hybrid symposium. Guests joined from more than 27 countries including the United Kingdom, Japan, India, Austria, and more!

Special thanks to all speakers, faculty, fellows, and staff involved in conducting the symposium! 

The DTRMP plays a critical collaborative role in numerous drug development and personalized therapeutics initiatives at Indiana University School of Medicine.

Services provided by the DTRMP include:

  • In silico predictions; in vitro/in vivo extrapolation
  • Preclinical study design – dosing, optimal sampling times
  • Preclinical data assessment – bioavailability, clearance, volume, half-life
  • Clinical study design – dosing, optimal sampling
  • Pharmacokinetic-pharmacodynamic modeling of preclinical & clinical data
  • Clinical data assessment – sources of inter-individual variability
  • Noncompartmental, population and mechanistic PK/PD modeling
  • MODEL-AD and TREAT-AD programs

Want to know more?

Interested in the DTRMP? Contact us for more information.